Effectiveness of drug therapy in hypertension: present status. A review.
D000959:Antihypertensive Agents / Q000266:history / Q000627:therapeutic use*; D002561:Cerebrovascular Disorders / Q000209:etiology; D003327:Coronary Disease / Q000209:etiology; D005128:Eye Diseases / Q000209:etiology; D005730:Ganglionic Blockers / Q000627:therapeutic use; D006145:Guanethidine / Q000627:therapeutic use; D006333:Heart Failure / Q000209:etiology; D006584:Hexamethonium Compounds / Q000627:therapeutic use; D006801:Humans; D006830:Hydralazine / Q000627:therapeutic use; D006852:Hydrochlorothiazide / Q000627:therapeutic use; D006973:Hypertension / Q000150:complications / Q000188:drug therapy / Q000401:mortality; D008297:Male; D008750:Methyldopa / Q000627:therapeutic use; D009203:Myocardial Infarction / Q000209:etiology; D010919:Placebos; D011379:Prognosis; D012110:Reserpine / Q000627:therapeutic use; D012160:Retina; D014511:Uremia / Q000209:etiology
D000959:Antihypertensive Agents; D005730:Ganglionic Blockers; D006584:Hexamethonium Compounds; D010919:Placebos; D006852:Hydrochlorothiazide; D006830:Hydralazine; D008750:Methyldopa; D012110:Reserpine; D006145:Guanethidine